The challenge of local control for non-small cell lung cancer: is it a key issue?

Abstract

Lung cancer remains a major challenge for radiation oncologists requiring a better treatment modality to overcome the high rate of local failures. Several trials have clearly demonstrated that a better local control is associated with a better survival. Those include combined approaches with chemotherapy, altered fractionation schedules and the new issue of dose escalation, which is now available due to the technical progress and will be discussed in detail.